<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02854943</url>
  </required_header>
  <id_info>
    <org_study_id>HLH</org_study_id>
    <nct_id>NCT02854943</nct_id>
  </id_info>
  <brief_title>The Prognostic and Diagnostic Value of Ferritin in Critically Ill Patients With Special Focus on Underlying Hemophagocytic Lymphohistiocytosis</brief_title>
  <official_title>The Prognostic and Diagnostic Value of Ferritin in Critically Ill Patients With Special Focus on Underlying Hemophagocytic Lymphohistiocytosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective analysis of ferritin, outcome and HLH-criteria in critically ill patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a retrospective register study of critically ill patients from Charité -
      University Medicine Berlin during 2000 and 2016 that had at least one measurement of plasma
      ferritin. Outcome, underlying diagnoses and HLH-2004 criteria (Henter JI et al. 2007) will be
      analysed and the HScore of these patients will be calculated (Fardet L et al. 2014). All
      recorded data of the specific admission term in ICU will be used for the analysis. No
      follow-up of the patients after discharge will be performed in this study. The study does not
      involve any randomization or any drug testing.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2000</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>Participants will be followed up for the duration of hospital stay, an expected average of two months</time_frame>
    <description>A retrospective analysis of patients with available charts to determine the outcome whether patients survived the ICU or died.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Probability of having undiagnosed Hemophagocytic lymphohistiocytosis (HLH)</measure>
    <time_frame>The participants will be followed up for the duration of hospital stay, an expected average of two months</time_frame>
    <description>Retrospective analysis of available charts, underlying diagnoses, findings and blood values: HLH-2004 criteria (Henter JI et al. 2007) and HScore (Fardet L et al. 2014)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnoses</measure>
    <time_frame>Participants will be followed up for the duration of hospital stay, an expected average of two months</time_frame>
    <description>Retrospective analysis of available charts and underlying diagnoses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive care unit stay</measure>
    <time_frame>Participants will be followed up for the duration of intensive care unit stay, an expected average of one week</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">258</enrollment>
  <condition>Hemophagocytic Lymphohistiocytosis</condition>
  <arm_group>
    <arm_group_label>Critically ill patients</arm_group_label>
    <description>Male and female critically ill patients admitted to the Charité - University Medicine Berlin during 2000 and 2016.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Male and female critically ill patients admitted to the Charité - Universitätsmedizin
        Berlin during 2000 and 2016
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male and female patients

          -  at least one measurement of plasma ferritin

        Exclusion Criteria:

        -age below 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudia Spies, MD, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Department of Anesthesiology and Intensive Care Medicine CVK/CCM, Charité - Universitätsmedizin Berlin</affiliation>
  </overall_official>
  <reference>
    <citation>Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007 Feb;48(2):124-31.</citation>
    <PMID>16937360</PMID>
  </reference>
  <reference>
    <citation>Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, Coppo P, Hejblum G. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014 Sep;66(9):2613-20. doi: 10.1002/art.38690.</citation>
    <PMID>24782338</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2016</study_first_submitted>
  <study_first_submitted_qc>August 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2016</study_first_posted>
  <last_update_submitted>August 3, 2016</last_update_submitted>
  <last_update_submitted_qc>August 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Claudia Spies</investigator_full_name>
    <investigator_title>Head of Department of Anesthesiology and Intensive Care Medicine CVK/CCM</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Lymphohistiocytosis, Hemophagocytic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

